{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:33:32Z","timestamp":1781238812941,"version":"3.54.1"},"reference-count":53,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,11]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Aberrant enhancer usage is a defining feature of oncogenic transcriptional reprogramming. Therapeutic strategies that disrupt enhancer-driven gene regulation may offer new treatment avenues. MYB is a key hematopoietic transcription factor that is frequently dysregulated in a broad range of cancers and plays a critical role in sustaining malignant cell states, including in aggressive leukemia subtypes such as KMT2A-rearranged leukemias. The molecular mechanisms by which it maintains oncogenic transcription remain incompletely understood. Here, we investigate the role of MYB in directing pathological enhancer activity to drive oncogene expression in leukemia. Using high-resolution Micro Capture-C, we show that upon MYB degradation, highly defined enhancer-promoter interactions at MYB binding sites are lost, correlating with the significant downregulation of target gene expression. When anchored to a gene desert region, the Myb transactivation domain (MybTA) is sufficient and necessary for the nucleation of an enhancer-like region. Critically, long-range chromatin interactions are established up to 400 kb away from where MybTA is anchored. This results in the activation of transcription from distal cryptic elements, which is reduced or abolished in the presence of point mutations that disrupt its interaction with the coactivators P300\/CBP. All these results indicate that MYB activity alone is sufficient to generate an enhancer, inducing transcription through precise enhancer-promoter cross talk, and identify the MYB-P300\/CBP axis as a therapeutically actionable vulnerability in enhancer-driven malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025030424","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:40:36Z","timestamp":1775655636000},"page":"2865-2878","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-3243","authenticated-orcid":false,"given":"I-Jun","family":"Lau","sequence":"first","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"2Oxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom"},{"name":"3Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Bloye","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-1407","authenticated-orcid":false,"given":"Alastair L.","family":"Smith","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe R.","family":"Harman","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"4Dark Blue Therapeutics Ltd, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Hamley","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilena","family":"Sharlandjieva","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Denny","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8326-5260","authenticated-orcid":false,"given":"Catherine","family":"Chahrour","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4895-0115","authenticated-orcid":false,"given":"Hangpeng","family":"Li","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2096-6878","authenticated-orcid":false,"given":"Nicole E.","family":"Jackson","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3931-0914","authenticated-orcid":false,"given":"Paresh","family":"Vyas","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"3Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4108-4357","authenticated-orcid":false,"given":"James O. J.","family":"Davies","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"5Radcliffe Department of Medicine, Oxford National Institute of Health Research Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8955-7256","authenticated-orcid":false,"given":"Jim R.","family":"Hughes","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9610-6763","authenticated-orcid":false,"given":"Nicholas T.","family":"Crump","sequence":"additional","affiliation":[{"name":"6Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0413-4271","authenticated-orcid":false,"given":"Thomas A.","family":"Milne","sequence":"additional","affiliation":[{"name":"1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"4Dark Blue Therapeutics Ltd, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2026061111221795100_bib1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"issue":"5","key":"2026061111221795100_bib2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.cell.2016.09.018","article-title":"Ever-changing landscapes: transcriptional enhancers in development and evolution","volume":"167","author":"Long","year":"2016","journal-title":"Cell"},{"issue":"10","key":"2026061111221795100_bib3","doi-asserted-by":"crossref","first-page":"e2300047","DOI":"10.1002\/bies.202300047","article-title":"Understanding fundamental principles of enhancer biology at a model locus: analysing the structure and function of an enhancer cluster at the \u03b1-globin locus","volume":"45","author":"Kassouf","year":"2023","journal-title":"Bioessays"},{"issue":"7","key":"2026061111221795100_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41580-024-00710-6","article-title":"Enhancer selectivity in space and time: from enhancer-promoter interactions to promoter activation","volume":"25","author":"Yang","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2026061111221795100_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"issue":"3","key":"2026061111221795100_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ng1966","article-title":"Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome","volume":"39","author":"Heintzman","year":"2007","journal-title":"Nat Genet"},{"issue":"1","key":"2026061111221795100_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13059-020-01957-w","article-title":"Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells","volume":"21","author":"Zhang","year":"2020","journal-title":"Genome Biol"},{"issue":"50","key":"2026061111221795100_bib8","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2026061111221795100_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0092-8674(91)90099-K","article-title":"A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis","volume":"65","author":"Mucenski","year":"1991","journal-title":"Cell"},{"issue":"30","key":"2026061111221795100_bib10","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1038\/sj.onc.1203660","article-title":"Initiation of adult myelopoiesis can occur in the absence of c-Myb whereas subsequent development is strictly dependent on the transcription factor","volume":"19","author":"Sumner","year":"2000","journal-title":"Oncogene"},{"issue":"3","key":"2026061111221795100_bib11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1182\/blood-2005-09-3846","article-title":"Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development","volume":"108","author":"Sakamoto","year":"2006","journal-title":"Blood"},{"issue":"15","key":"2026061111221795100_bib12","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1101\/gad.17269211","article-title":"An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance","volume":"25","author":"Zuber","year":"2011","journal-title":"Genes Dev"},{"key":"2026061111221795100_bib13","first-page":"15","article-title":"Emerging role of MYB transcription factors in cancer drug resistance","volume":"7","author":"Biersack","year":"2024","journal-title":"Cancer Drug Resist"},{"issue":"6215","key":"2026061111221795100_bib14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1126\/science.1259037","article-title":"An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element","volume":"346","author":"Mansour","year":"2014","journal-title":"Science"},{"issue":"2","key":"2026061111221795100_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.devcel.2004.12.015","article-title":"c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation","volume":"8","author":"Sandberg","year":"2005","journal-title":"Dev Cell"},{"issue":"5","key":"2026061111221795100_bib16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1101\/gad.10.5.528","article-title":"CBP as a transcriptional coactivator of c-Myb","volume":"10","author":"Dai","year":"1996","journal-title":"Genes Dev"},{"issue":"9","key":"2026061111221795100_bib17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1158\/1541-7786.MCR-09-0070","article-title":"Mutations in multiple domains of c-Myb disrupt interaction with CBP\/p300 and abrogate myeloid transforming ability","volume":"7","author":"Pattabiraman","year":"2009","journal-title":"Mol Cancer Res"},{"issue":"26","key":"2026061111221795100_bib18","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1182\/blood-2010-04-269951","article-title":"A recessive screen for genes regulating hematopoietic stem cells","volume":"116","author":"Papathanasiou","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2026061111221795100_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10565-024-09984-0","article-title":"The important role of the histone acetyltransferases p300\/CBP in cancer and the promising anticancer effects of p300\/CBP inhibitors","volume":"41","author":"Wu","year":"2025","journal-title":"Cell Biol Toxicol"},{"issue":"7414","key":"2026061111221795100_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11279","article-title":"The long-range interaction landscape of gene promoters","volume":"489","author":"Sanyal","year":"2012","journal-title":"Nature"},{"issue":"6409","key":"2026061111221795100_bib21","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1126\/science.aau0320","article-title":"Developmental enhancers and chromosome topology","volume":"361","author":"Furlong","year":"2018","journal-title":"Science"},{"issue":"13","key":"2026061111221795100_bib22","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1093\/nar\/gkz462","article-title":"Acute depletion of CTCF directly affects MYC regulation through loss of enhancer-promoter looping","volume":"47","author":"Hyle","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026061111221795100_bib23","doi-asserted-by":"crossref","first-page":"102023","DOI":"10.1016\/j.gde.2023.102023","article-title":"Recent progress and challenges in single-cell imaging of enhancer-promoter interaction","volume":"79","author":"Chen","year":"2023","journal-title":"Curr Opin Genet Dev"},{"issue":"4","key":"2026061111221795100_bib24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41588-024-01681-2","article-title":"Increased enhancer-promoter interactions during developmental enhancer activation in mammals","volume":"56","author":"Chen","year":"2024","journal-title":"Nat Genet"},{"issue":"5","key":"2026061111221795100_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2023.12.023","article-title":"Chromatin gene-gene loops support the cross-regulation of genes with related function","volume":"84","author":"Pollex","year":"2024","journal-title":"Mol Cell"},{"issue":"2","key":"2026061111221795100_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2024.11.037","article-title":"LDB1 establishes multi-enhancer networks to regulate gene expression","volume":"85","author":"Aboreden","year":"2025","journal-title":"Mol Cell"},{"issue":"7865","key":"2026061111221795100_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-021-03639-4","article-title":"Defining genome architecture at base-pair resolution","volume":"595","author":"Hua","year":"2021","journal-title":"Nature"},{"issue":"20","key":"2026061111221795100_bib28","doi-asserted-by":"crossref","first-page":"e113150","DOI":"10.15252\/embj.2022113150","article-title":"Pioneer activity distinguishes activating from non-activating SOX2 binding sites","volume":"42","author":"Maresca","year":"2023","journal-title":"The EMBO J"},{"issue":"6","key":"2026061111221795100_bib29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41588-023-01391-1","article-title":"Region Capture Micro-C reveals coalescence of enhancers and promoters into nested microcompartments","volume":"55","author":"Goel","year":"2023","journal-title":"Nat Genet"},{"issue":"10","key":"2026061111221795100_bib30","doi-asserted-by":"crossref","first-page":"e2200240","DOI":"10.1002\/bies.202200240","article-title":"The dynamic role of cohesin in maintaining human genome architecture","volume":"45","author":"Agarwal","year":"2023","journal-title":"Bioessays"},{"issue":"8","key":"2026061111221795100_bib31","doi-asserted-by":"crossref","first-page":"194564","DOI":"10.1016\/j.bbagrm.2020.194564","article-title":"MLL-rearranged infant leukaemia: a 'thorn in the side' of a remarkable success story","volume":"1863","author":"Rice","year":"2020","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"12","key":"2026061111221795100_bib32","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":"Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"2026061111221795100_bib33","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.cell.2014.05.004","article-title":"Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation","volume":"157","author":"Blackledge","year":"2014","journal-title":"Cell"},{"issue":"1","key":"2026061111221795100_bib34","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/s41467-019-10844-3","article-title":"DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation","volume":"10","author":"Godfrey","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"2026061111221795100_bib35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.celrep.2016.12.054","article-title":"MLL-AF4 spreading identifies binding sites that are distinct from super-enhancers and that govern sensitivity to DOT1L inhibition in leukemia","volume":"18","author":"Kerry","year":"2017","journal-title":"Cell Rep"},{"issue":"1","key":"2026061111221795100_bib36","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1038\/s41467-023-40981-9","article-title":"MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia","volume":"14","author":"Crump","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"2026061111221795100_bib37","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nmeth.2688","article-title":"Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position","volume":"10","author":"Buenrostro","year":"2013","journal-title":"Nat Methods"},{"issue":"6290","key":"2026061111221795100_bib38","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.aad9841","article-title":"TT-seq maps the human transient transcriptome","volume":"352","author":"Schwalb","year":"2016","journal-title":"Science"},{"issue":"2","key":"2026061111221795100_bib39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41596-021-00651-w","article-title":"Capture-C: a modular and flexible approach for high-resolution chromosome conformation capture","volume":"17","author":"Downes","year":"2022","journal-title":"Nat Protoc"},{"issue":"1","key":"2026061111221795100_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nmeth.3664","article-title":"Multiplexed analysis of chromosome conformation at vastly improved sensitivity","volume":"13","author":"Davies","year":"2016","journal-title":"Nat Methods"},{"issue":"6","key":"2026061111221795100_bib41","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41596-023-00817-8","article-title":"Determining chromatin architecture with Micro Capture-C","volume":"18","author":"Hamley","year":"2023","journal-title":"Nat Protoc"},{"issue":"5","key":"2026061111221795100_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41589-018-0021-8","article-title":"The dTAG system for immediate and target-specific protein degradation","volume":"14","author":"Nabet","year":"2018","journal-title":"Nat Chem Biol"},{"issue":"12","key":"2026061111221795100_bib43","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.celrep.2015.12.003","article-title":"MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199","volume":"13","author":"Benito","year":"2015","journal-title":"Cell Rep"},{"issue":"1","key":"2026061111221795100_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41467-020-20400-z","article-title":"BET inhibition disrupts transcription but retains enhancer-promoter contact","volume":"12","author":"Crump","year":"2021","journal-title":"Nat Commun"},{"issue":"15","key":"2026061111221795100_bib45","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1073\/pnas.86.15.5758","article-title":"Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene","volume":"86","author":"Sakura","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026061111221795100_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-8674(89)90405-4","article-title":"Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb","volume":"58","author":"Weston","year":"1989","journal-title":"Cell"},{"issue":"5","key":"2026061111221795100_bib47","first-page":"657","article-title":"Transcriptional activation by human c-myb and v-myb genes","volume":"5","author":"Kalkbrenner","year":"1990","journal-title":"Oncogene"},{"issue":"7345","key":"2026061111221795100_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature09906","article-title":"Mapping and analysis of chromatin state dynamics in nine human cell types","volume":"473","author":"Ernst","year":"2011","journal-title":"Nature"},{"issue":"5218","key":"2026061111221795100_bib49","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1126\/science.7792603","article-title":"Transcriptional activation by tetracyclines in mammalian cells","volume":"268","author":"Gossen","year":"1995","journal-title":"Science"},{"issue":"8","key":"2026061111221795100_bib50","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1128\/MCB.19.8.5601","article-title":"Role of secondary structure in discrimination between constitutive and inducible activators","volume":"19","author":"Parker","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2026061111221795100_bib51","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jmb.2004.01.038","article-title":"Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb","volume":"337","author":"Zor","year":"2004","journal-title":"J Mol Biol"},{"issue":"1","key":"2026061111221795100_bib52","doi-asserted-by":"crossref","first-page":"11780","DOI":"10.1038\/s41598-025-96248-4","article-title":"Active regulatory elements recruit cohesin to establish cell-specific chromatin domains","volume":"15","author":"Georgiades","year":"2025","journal-title":"Sci Rep"},{"issue":"12","key":"2026061111221795100_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.11.001","article-title":"Therapeutic targeting of EP300\/CBP by bromodomain inhibition in hematologic malignancies","volume":"41","author":"Nicosia","year":"2023","journal-title":"Cancer Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/24\/2865\/2525840\/blood_bld-2025-030424-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/24\/2865\/2525840\/blood_bld-2025-030424-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:22:29Z","timestamp":1781191349000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/24\/2865\/567286\/MYB-activity-drives-emergent-enhancer-activation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":53,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026,6,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025030424","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,11]]},"published":{"date-parts":[[2026,6,11]]}}}